• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病小鼠和人类的肝转录组特征。

Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.

机构信息

Department of Laboratory Animal Science, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Animal Model Exp Med. 2023 Aug;6(4):317-328. doi: 10.1002/ame2.12338. Epub 2023 Aug 11.

DOI:10.1002/ame2.12338
PMID:37565549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10486336/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is the main reason for cirrhosis and hepatocellular carcinoma. As a starting point for NAFLD, the treatment of nonalcoholic fatty liver (NAFL) is receiving increasing attention. Mice fed a high-fat diet (HFD) and hereditary leptin deficiency (ob/ob) mice are important NAFL animal models. However, the comparison of these mouse models with human NAFL is still unclear.

METHODS

In this study, HFD-fed mice and ob/ob mice were used as NAFL animal models. Liver histopathological characteristics were compared, and liver transcriptome from both mouse models was performed using RNA sequencing (RNA-seq). RNA-seq data obtained from the livers of NAFL patients was downloaded from the GEO database. Global gene expression profiles in the livers were further analyzed using functional enrichment analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway.

RESULTS

Our results showed that the biochemical parameters of both mouse models and human NAFL were similar. Compared with HFD-fed mice, ob/ob mice were more similar in histologic appearance to NAFL patients. The liver transcriptome characteristics partly overlapped in mice and humans. Furthermore, in the NAFL pathway, most genes showed similar trends in mice and humans, thus demonstrating that both types of mice can be used as models for basic research on NAFL, considering the differences.

CONCLUSION

Our findings show that HFD-fed mice and ob/ob mice can mimic human NAFL partly in pathophysiological process. The comparative analysis of liver transcriptome profile in mouse models and human NAFL presented here provides insights into the molecular characteristics across these NAFL models.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是肝硬化和肝细胞癌的主要原因。作为 NAFLD 的起点,非酒精性脂肪肝(NAFL)的治疗受到越来越多的关注。高脂肪饮食(HFD)喂养的小鼠和遗传性瘦素缺乏(ob/ob)小鼠是重要的 NAFL 动物模型。然而,这些小鼠模型与人类 NAFL 的比较仍不清楚。

方法

本研究以 HFD 喂养的小鼠和 ob/ob 小鼠作为 NAFL 动物模型。比较肝脏组织病理学特征,并对两种模型的肝脏转录组进行 RNA 测序(RNA-seq)。从 GEO 数据库下载来自 NAFL 患者肝脏的 RNA-seq 数据。使用功能富集分析和京都基因与基因组百科全书(KEGG)途径对肝脏中的全基因表达谱进行进一步分析。

结果

我们的结果表明,两种小鼠模型和人类 NAFL 的生化参数相似。与 HFD 喂养的小鼠相比,ob/ob 小鼠在组织学外观上与 NAFL 患者更相似。小鼠和人类的肝脏转录组特征部分重叠。此外,在 NAFL 途径中,大多数基因在小鼠和人类中表现出相似的趋势,因此表明这两种类型的小鼠都可以作为 NAFL 基础研究的模型,同时考虑到它们之间的差异。

结论

我们的研究结果表明,HFD 喂养的小鼠和 ob/ob 小鼠在病理生理过程中可以部分模拟人类的 NAFL。本文对小鼠模型和人类 NAFL 的肝脏转录组谱进行的比较分析为这些 NAFL 模型的分子特征提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/f7987f3be015/AME2-6-317-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/a67abfe64a45/AME2-6-317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/fc446bbf34cd/AME2-6-317-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/b969a307e04b/AME2-6-317-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/d65e8d7ef7dd/AME2-6-317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/3049b2ec9b57/AME2-6-317-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/f7987f3be015/AME2-6-317-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/a67abfe64a45/AME2-6-317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/fc446bbf34cd/AME2-6-317-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/b969a307e04b/AME2-6-317-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/d65e8d7ef7dd/AME2-6-317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/3049b2ec9b57/AME2-6-317-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1d5/10486336/f7987f3be015/AME2-6-317-g003.jpg

相似文献

1
Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.非酒精性脂肪性肝病小鼠和人类的肝转录组特征。
Animal Model Exp Med. 2023 Aug;6(4):317-328. doi: 10.1002/ame2.12338. Epub 2023 Aug 11.
2
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
3
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
4
Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.非酒精性脂肪性肝病表现出纤维化前和癌前的分子特征。
Dig Dis Sci. 2019 May;64(5):1257-1269. doi: 10.1007/s10620-018-5398-4. Epub 2018 Dec 5.
5
Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.非酒精性脂肪性肝病相关的 DNA 甲基化和基因表达改变在喂食肥胖型高脂肪高蔗糖饮食的合作杂交小鼠肝脏中。
Epigenetics. 2022 Nov;17(11):1462-1476. doi: 10.1080/15592294.2022.2043590. Epub 2022 Mar 24.
6
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
7
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.与胰岛素抵抗指数相关的肝脏转录组特征解释了早期非酒精性脂肪性肝病的发病机制。
Ann Hepatol. 2020 Sep-Oct;19(5):472-481. doi: 10.1016/j.aohep.2020.06.009. Epub 2020 Jul 15.
8
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.比较非酒精性脂肪性肝病小鼠模型和患者肝组织的基因表达谱。
Gastroenterology. 2016 Sep;151(3):513-525.e0. doi: 10.1053/j.gastro.2016.05.051. Epub 2016 Jun 16.
9
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.利拉鲁肽、奥贝胆酸和 Elafibranor 在经活检证实的非酒精性脂肪性肝炎肥胖小鼠模型中的代谢和肝脏作用。
World J Gastroenterol. 2018 Jan 14;24(2):179-194. doi: 10.3748/wjg.v24.i2.179.
10
Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.组氨酸脱羧酶敲除通过破坏组胺/瘦素信号预防高脂肪饮食喂养的小鼠胆管细胞损伤和肝纤维化。
Am J Pathol. 2018 Mar;188(3):600-615. doi: 10.1016/j.ajpath.2017.11.016. Epub 2017 Dec 15.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Heterozygous GAA knockout is nonconsequential on metabolism and the spatial liver transcriptome in high-fat diet-induced obese and prediabetic mice.在高脂饮食诱导的肥胖和糖尿病前期小鼠中,杂合型GAA基因敲除对代谢和肝脏空间转录组无影响。
Physiol Rep. 2025 Mar;13(6):e70276. doi: 10.14814/phy2.70276.
3
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling.

本文引用的文献

1
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.全球非酒精性脂肪性肝病发病率:63 项研究和 1,201,807 人的系统评价和荟萃分析。
J Hepatol. 2023 Aug;79(2):287-295. doi: 10.1016/j.jhep.2023.03.040. Epub 2023 Apr 9.
2
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
3
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
血清半乳糖凝集素-1作为代谢功能障碍相关脂肪性肝病诊断生物标志物的可行性:一项采用便利抽样法对部分中国人群的研究。
Biomedicines. 2025 Feb 10;13(2):425. doi: 10.3390/biomedicines13020425.
4
Pathogenicity and transcriptomic profiling reveals immunology molecular hallmarks after CA10 virus infection.CA10 病毒感染后的致病机制和转录组特征分析揭示了免疫学的分子特征。
Animal Model Exp Med. 2024 Oct;7(5):717-731. doi: 10.1002/ame2.12415. Epub 2024 May 15.
5
Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.免疫相关基因在非酒精性脂肪性肝病不同阶段的表达及可能的调控机制。
Front Immunol. 2024 Mar 8;15:1364442. doi: 10.3389/fimmu.2024.1364442. eCollection 2024.
6
Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control.间质基质细胞的治疗效果需要线粒体转移和质量控制。
Int J Mol Sci. 2023 Oct 31;24(21):15788. doi: 10.3390/ijms242115788.
超重和肥胖人群中非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球患病率:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16.
4
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).美国临床内分泌学会临床实践指南:原发性保健和内分泌学临床环境中非酒精性脂肪性肝病的诊断和管理:由美国肝病研究协会(AASLD)共同赞助。
Endocr Pract. 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010.
5
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.非酒精性脂肪性肝病与心血管风险:美国心脏协会的科学声明
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185. doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
6
Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis.金利达颗粒通过拮抗肝细胞焦亡改善高脂饮食诱导的小鼠肝损伤。
Pharm Biol. 2022 Dec;60(1):274-281. doi: 10.1080/13880209.2022.2029501.
7
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
8
Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats.转录组学和脂质组学联合分析揭示大鼠早期脂肪肝疾病中基因表达失调和脂质代谢谱
Front Nutr. 2021 Sep 17;8:733197. doi: 10.3389/fnut.2021.733197. eCollection 2021.
9
Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.肥胖(ob/ob)和糖尿病(db/db)小鼠的新见解:同一枚硬币的两面。
Microbiome. 2021 Jun 28;9(1):147. doi: 10.1186/s40168-021-01097-8.
10
A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD.一项非酒精性脂肪性肝病动物模型的系统评价发现,高脂肪、高果糖饮食最接近人类非酒精性脂肪性肝病。
Hepatology. 2021 Oct;74(4):1884-1901. doi: 10.1002/hep.31897. Epub 2021 Jun 17.